Why Control Bionics' (ASX:CBL) NeuroNode technology is a lifeline for ALS patients

Why Control Bionics’ (ASX:CBL) NeuroNode technology is a lifeline for ALS patients

Be the First to Comment
Read

• Home
• Sponsored

Sponsored
Why Control Bionics’ (ASX:CBL) NeuroNode technology is a lifeline for ALS patients

June 23, 2022 11:08 AM AEST

Be the First to Comment

NEW

• Manisha

  Author

  Manisha – Senior Financial Journalist

  305 Posts

  Manisha is a Senior Financial Journalist at Kalkine Media, covering the Australian market along with world news. She has tons of experience in content development in the media industry. Her deliverables reflect the strong command she has over the lan…

• Shwetambri Chauhan

  Reviewer

  Shwetambri Chauhan – Sr. Research Editor

  0 Posts

  Shwetambri Chauhan is a Sr. Research Editor at Kalkine Media. She comes with an experience of 11 years in secondary research and quality check. Besides, she has rich experience of working across different sectors and markets. Her professional experie…

  Follow

MOST READ

Stock Market
ASX 200 to rise; Wall Street settles lower; oil prices slip

Cryptocurrency
Why did Muse (MUSE) crypto volume soar over 1000%?

Cryptocurrency
Why is Meta Ruffy (MR) rising, defying crypto market dip?

Image source: Company announcement

Highlights

• Control Bionics has been making life-changing connections for people with movement and speech disabilities.
• The company’s world-class patented NeuroNode technology [...]